Studies how sex and obesity affect blood vessel widening in low oxygen
Studies nerve system effects on blood vessel widening in adults with obesity.
Key facts
- Who runs it
- University of Missouri-Columbia
- Where
- Columbia, United StatesSee the site
- Trial code
- Registry title
- Sex Disparities in Hypoxic Vasodilation and Impact of Obesity
- Status
- Recruiting
- Phase
- Early phase 1
- People taking part
- 72 people, planned
- Started
- 14 Mar 2023
- Expected to end
- 30 Jul 2027
- Type of study
- Interventional
- Treatments tested
- Propranolol Hydrochloride
- Isoproterenol
- Phentolamine Mesylate
- Norepinephrine
- Record updated
- 28 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 45 with a BMI above 18 kg/m2 and without major health problems. It studies sex differences in how blood vessels widen when oxygen is low, and the effect of obesity.
- Age
- 18 Years to 45 Years
- Sex
- All sexes can join.
- Earlier treatment
- People taking prescription medications cannot join. People on anticoagulation therapy cannot join.
Main reasons for not taking part
- Pregnancy or breastfeeding
- Diagnosed sleep apnea or AHI >10 events/hr
- Current smoking or nicotine use
- Cardiovascular, liver, kidney or lung disease, or blood pressure ≥140/90 mmHg
- Diabetes or polycystic ovarian syndrome
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- BMI >18 kg/m2
Who cannot take part
- Prescription medications, Sensitivity to lidocaine
- Increased risk of bleeding, pro-coagulant disorders, clotting disorders, anticoagulation therapy
- Nerve/neurologic disease
- Cardiovascular, hepatic, renal, respiratory disease
- Diabetes, Polycystic ovarian syndrome
- Pregnancy, breastfeeding
- Diagnosed sleep apnea or AHI >10 events/hr
- Current smoking/Nicotine use
- Blood pressure ≥140/90 mmHg
- Communication barriers
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 45 years old?
Where in United States
- University of MissouriColumbia, United StatesContact: Jennifer L HarperTaking people
About the trial
What the trial wants to find out
The purpose of this project is to examine key mechanisms contributing to sex-differences in hypoxic vasodilation and the impact of obesity, with particular emphasis on the sympathetic nervous system.
The group in the trial
- Hypoxia ExposureOther group
Men and women will be exposed to isocapnic hypoxia. Participants will wear a mask and systemic oxygen levels will be titrated to attain hypoxemia as assessed by pulse oximetry.
Treatment: Propranolol Hydrochloride, Isoproterenol, Phentolamine Mesylate, and Norepinephrine
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Sex Disparities in Hypoxic Vasodilation and Impact of Obesity
- Plain-language title
- Studies how sex and obesity affect blood vessel widening in low oxygenGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05219799, who can take part
- Record updated
- 28 July 2026